The Propeller Platform
Our FDA-cleared digital therapeutic platform includes CE-marked sensors to track your medications, a mobile app or online portal, and personalized support and coaching every step of the way.
Join the 140,000+ patients using Propeller
Identify your triggers and better understand what’s causing flare-ups so you can confidently plan for the day ahead.
Propeller is clinically proven to reduce the use of rescue inhalers,Merchant et al., (2016). Effectiveness of population health management using the propeller health asthma platform: a randomized clinical trial. J Allergy Clin Immunol Pract,Chen et al., (2019). Passive monitoring of short-acting beta-agonist use via digital platform in patients with chronic obstructive pulmonary disease: quality improvement retrospective analysis. JMIR and research shows people using Propeller have fewer trips to the hospital or emergency room.Merchant et al., (2018). Impact of a Digital Health Intervention on Asthma Resource Utilization. WAOJ,Alshabani et al., (2019). J. Electronic Inhaler Monitoring and Healthcare Utilization in Chronic Obstructive Pulmonary Disease. Telemedicine and Telecare
Propeller helps people with asthma or COPD have more days with better breathing,Mosnaim et al., (2021). The Impact of Patient Self-Monitoring Via Electronic Medication Monitor and Mobile App Plus Remote Clinician Feedback on Adherence to Inhaled Corticosteroids: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. *Better breathing defined as days without SABA use.,Chen et al., (2019). Passive monitoring of short-acting beta-agonist use via digital platform in patients with chronic obstructive pulmonary disease: quality improvement retrospective analysis. JMIR. *Better breathing defined as days without SABA use. so you can get back to doing the things you love.
A proven end-to-end digital therapeutic platform
The Propeller Platform includes sensors for medication tracking, a mobile app or online portal, personalized support and coaching, and clinical data for physician monitoring. The platform helps you work with your doctor so they can better understand your breathing and personalize your treatment.
Digital Therapeutics platform for chronic conditions offers patients and clinicians precise interventions and personalized experiences at scale.
Person-first language around condition, adherence, triggers, inhalation technique, and health trends empower patients to take control of their health.
Patients benefit from personalized care with live and virtual support that keeps them motivated and focused on achieving their goals.
Data-driven trend analysis alerts patients and physicians when something’s off, helping prevent costly ER visits and enabling effective self-management.
Unifying value for all partners in health
Lower healthcare utilizationMerchant et al., (2018). Impact of a Digital Health Intervention on Asthma Resource Utilization. WAOJ,Alshabani et al., (2019). J. Electronic Inhaler Monitoring and Healthcare Utilization in Chronic Obstructive Pulmonary Disease. Telemedicine and Telecare and cost of care at scale
For Health Systems
Reduced unnecessary resource utilization, reimbursement opportunities, and improved care team efficiency
For Pharma and Life Sciences
Precision medication optimization and unmatched global connected drug delivery
Health systems faced major headwinds in 2022: ongoing clinician burnout, soaring staffing shortages, and plummeting financial margins. Fortunately, the healthcare industry has been actively restructuring its landscape and building new momentum in reimbursement, value-based care, and patient engagement. With all the fundamental shifts to come in 2023, health systems have the most to gain… and the most to lose if they don’t take prompt action.
Here are the most pressing changes health systems can expect – and should immediately prepare for:
New CMS rulemaking on remote therapeutic monitoring is more practical for health systems
Between the rising global prevalence of chronic disease and a rapidly growing digital-first movement in healthcare, the development of connected drug delivery devices has increased significantly over the last several years.
Even before the COVID-19 pandemic, the connected drug delivery devices market was experiencing steady growth. By the end of 2020, the market had grown 23.8% compared to the previous year.1 This expansion indicates that more than ever, embedding electronics and sensors into drug delivery devices including inhalers and injector pens is becoming more widely adopted.
More than 90,000 new digital health solutions entered the market in 2020,1 and annual growth is expected to increase 27% over the next 8 years.2 For health systems, this creates an unprecedented opportunity to leverage digital solutions, especially considering: expanded reimbursement opportunities for remote monitoring, soaring patient engagement, and increased physician demand.
With so many digital options available, comprehensive partner evaluations are critical for identifying solutions with staying power, ensuring successful implementation, and developing the necessary infrastructure to support integration at scale. If health systems aren’t asking the right questions during their value assessments, they won’t see a return on their investments.
These are the top 5 questions health systems must consider before heading into their digital partner evaluations:
Propeller Health is a precision digital health company on a mission to uplift the lives of patients with chronic respiratory disease and bring real, measurable value to each corner of the healthcare ecosystem.